Drugs / Infanrix-IPV+Hib™
Trials 1 · a red edge is where a trial was stopped
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 3 | NCT01086423 | Mar → Nov 2010 | diphtheria, haemophilus infectious disease, poliomyelitis, tetanus | GlaxoSmithKline | Completed | No outcome recorded |
Evidence & citations 3 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | Infanrix-IPV+Hib | “received 3 doses of Infanrix™-IPV+Hib vaccine at 2, 3 and 4 months of age” NCT01086423 ↗ |
| Modality | Vaccine | “Infanrix-IPV+Hib™ Vaccine” NCT01086423 ↗ |
| Route | Intramuscular | “administered intramuscularly in the upper side of the right thigh” NCT01086423 ↗ |